New Quantum Blue® TDM Assays
BÜHLMANN is proud to introduce Quantum Blue® Anti-Infliximab (RUO) and Anti-Adalimumab (RUO) to the TDM rapid test portfolio. These new assays together with the infliximab and adalimumab trough level rapid tests offer the complete package for infliximab and adalimumab TDM testing on the popular Quantum Blue® platform.
BÜHLMANN Quantum Blue® Anti-Infliximab and Quantum Blue® Anti-Adalimumab are for Research Use Only in the US. Not for use in diagnostics procedures in the US.